FDA Adverse Event Injury Summary report: N

COREVALVE

MDR report key: 3870565 · Received June 12, 2014

Report

Report Number
2025587-2014-00377
Event Type
Injury
Date Received
June 12, 2014
Date of Event
May 1, 2014
Report Date
March 5, 2019
Manufacturer
MEDTRONIC HEART VALVES DIVISION
Product Code
NPT
PMA / PMN Number
P130021
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

PRODUCT ANALYSIS: THE PRODUCT REMAINS IMPLANTED, THEREFORE NO PRODUCT ANALYSIS CAN BE PERFORMED. CONCLUSION: BASED ON THE INFORMATION PROVIDED, THE REPORTED POSITIONING ISSUE THAT REQUIRED REINTERVENTION COULD POSSIBLY BE RELATED TO PATIENT ANATOMY AND/OR IMPLANT POSITION. POSITIONING IS DEPENDENT ON PATIENT ANATOMY AS WELL AS USER TECHNIQUE. POTENTIAL FACTORS THAT CAN INFLUENCE IMPLANT POSITION INCLUDE TENSION APPLIED ON THE DELIVERY CATHETER SYSTEM (DCS) DURING POSITIONING, CALCIFICATION LEVELS IN THE NATIVE VESSEL AND COMPLIANCE OF THE AORTA AND NATIVE VESSELS. THE PROCEDURE WAS SUCCESSFULLY COMPLETED WITH NO ADVERSE PATIENT EFFECTS REPORTED. THE ROOT CAUSE FOR THIS REPORT COULD NOT BE ESTABLISHED FROM THE INFORMATION AVAILABLE. (B)(4).

Additional Manufacturer Narrative · 1

IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Additional Manufacturer Narrative · 1

IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

MEDTRONIC RECEIVED INFORMATION THAT DURING THE IMPLANT OF THIS TRANSCATHETER BIOPROSTHETIC VALVE, THE FIRST VALVE WAS NOT FULLY DEPL OYED AND IT WAS FELT THAT THE ANGLE OF IMPLANTATION WAS SUBOPTIMAL IN THE LEFT CORONARY REGION. THE VALVE COULD NOT BE RETRIEVED FROM THE PATIENT AND WAS DEPLOYED IN THE AORTIC ARCH. A SECOND VALVE WAS IMPLANTED SUCCESSFULLY WITH NO ADVERSE PATIENT EFFECTS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
348011 COREVALVE AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED NPT MEDTRONIC HEART VALVES DIVISION MCS-P3-3143

Patients

Seq Age Sex Outcome Treatment
1 00085 YR Required Intervention